Papalocal
Loading…
Papalocal · People

Helen Hobbs

American molecular geneticist
1952 – present · university teacher · United States
24 facts · 1 confirmed
This profile was compiled from public sources, and may be incomplete or out of date. Are you Helen Hobbs? Sign in to claim your People Profile — edit it, add your input, or request changes/removal.

Helen Hobbs is an American molecular geneticist. Born May 5, 1952, in Boston. Educated at Stanford University. Awards include Pearl Meister Greengard Prize, Breakthrough Prize in Life Sciences and Heinrich Wieland Prize.

Facts

24 facts · 1 confirmed by two sources · 13 cited · 10 from one source

Where this comes from

Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.

What Wikidata says · copied November 19, 2026 · revision 2562703187
Described as
American molecular geneticist
Other names
Helen Haskell Hobbs
Born
May 5, 1952 · 1 reference
Born in
Boston
Citizen of
United States
Occupation
university teacher; biochemist; physician · 1 reference; molecular geneticist; researcher · 1 reference
Worked for
University of Texas System; Howard Hughes Medical Institute (2002–) · 2 references; University of Texas Southwestern Medical Center · 1 reference
Education
Stanford University
Member of
American Academy of Arts and Sciences (2006–) · 1 reference; National Academy of Sciences (2007–) · 1 reference
Awards
Pearl Meister Greengard Prize (2015) · 1 reference; Breakthrough Prize in Life Sciences (2016) · 1 reference; Heinrich Wieland Prize (2005) · 1 reference; Jay and Jeanie Schottenstein prize in cardiovascular science (2017) · 1 reference; Robert J. and Claire Pasarow Foundation Award for Distinguished Contributions to Cardiovascular Research (2013) · 1 reference; honorary doctor of the University of Ferrara (2003); Fellow of the American Association for the Advancement of Science (2015) · 1 reference; George M. Kober Lectureship (2018) · 1 reference; Howard Taylor Ricketts Prize (2022) · 1 reference; Scientific Grand Prize of the Lefoulon-Delalande Fondation (2018) · 1 reference
Wikipedias with a page
10

Wikidata item Q21433424 (wikidata.org/wiki/Q21433424), public domain (CC0). Copied November 19, 2026.

What Wikipedia says · copied November 19, 2026 · revision 1381365639

Helen Haskell Hobbs (born May 5, 1952 in Boston, Massachusetts) is an American medical researcher who is professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute Investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2018 Harrington Prize for Innovation in Medicine. Hobbs specializes in the dysregulation of lipid metabolism and how it affects human diseases. She and Jonathan C. Cohen found that people with hypomorphic PCSK9 mutations had lower LDL-cholesterol levels and were almost immune to heart disease. This finding led to the development of a new class of cholesterol-lowering drugs that mimic the effects of the PCSK9 mutations. She and Cohen also identified the first genetic risk factor for fatty liver disease, a burgeoning health problem that can lead to cirrhosis and liver cancer. Their laboratory has shown that mutation in PNPLA3 causes accumulation of PNPLA3 on lipid droplets, which compromises the mobilization of triglycerides from liver cells. She sits on the Board of Directors at Pfizer.

Born, in its opening lines
May 5, 1952

From the Wikipedia article “Helen Hobbs” (en.wikipedia.org/wiki/Helen_Hobbs), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied November 19, 2026; not changed.

Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.

Papalocal’s own record, started from Wikidata and Wikipedia.Report / request a correction